Henny Azmanov
Clinical FellowAbout
Research
Publications
2026
A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's disease
Lehmann H, Azmanov H, Hershkovitz Y, Hurvitz N, Agus S, Berg M, Arkadir D, Ilan Y. A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's disease. IBRO Neuroscience Reports 2026, 20: 448-456. PMID: 41853628, PMCID: PMC12993379, DOI: 10.1016/j.ibneur.2026.02.019.Peer-Reviewed Original ResearchWhat is new in pleural infections?
Kenig A, Azmanov H, Alsharif N, Idais I, Kuint R, Darawshy F, Kuint R. What is new in pleural infections? Breathe 2026, 22: 250038. PMID: 41853055, PMCID: PMC12993744, DOI: 10.1183/20734735.0038-2025.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2025
Fire: argon plasma coagulation, diathermy and laser
Azmanov H, Darawshy F. Fire: argon plasma coagulation, diathermy and laser. Breathe 2025, 21: 240246. PMID: 40673066, PMCID: PMC12260910, DOI: 10.1183/20734735.0246-2024.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNon-classical pulmonary exacerbation in cystic fibrosis revealing ALK-Translocated lung cancer: A case report
Hadhud M, Arnon J, Hershko-Moshe A, Hollander A, Hurvitz-Lehmann N, Potruch A, Azmanov H, Kuint R, Hiller N, Picard E, Sebbag-Sznajder N, Leebhoff S, Wilschanski M, Grunewald M, Birimberg-Schwartz L, Cohen-Cymberknoh M. Non-classical pulmonary exacerbation in cystic fibrosis revealing ALK-Translocated lung cancer: A case report. Respiratory Medicine Case Reports 2025, 53: 102171. PMID: 39980610, PMCID: PMC11841201, DOI: 10.1016/j.rmcr.2025.102171.Peer-Reviewed Original Research
2024
Prevalence and Clinical Implications of Nontuberculous Mycobacteria Isolation and Infection among Patients with Bronchiectasis in the Jerusalem Area.
Kuint R, Azmanov H, Shalom A, Berkman N. Prevalence and Clinical Implications of Nontuberculous Mycobacteria Isolation and Infection among Patients with Bronchiectasis in the Jerusalem Area. Israel Medical Association Journal 2024, 26: 180-185. PMID: 38493330.Peer-Reviewed Original Research
2023
Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic Inflammation
Kenig A, Keidar-Haran T, Azmanov H, Kessler A, Kolben Y, Tayri-Wilk T, Kalisman N, Weksler-Zangen S, Ilan Y. Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic Inflammation. Inflammation 2023, 46: 963-974. PMID: 36656466, DOI: 10.1007/s10753-023-01783-9.Peer-Reviewed Original ResearchUsing chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections
Kolben Y, Azmanov H, Gelman R, Dror D, Ilan Y. Using chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections. Annals Of Medicine 2023, 55: 311-318. PMID: 36594558, PMCID: PMC9815249, DOI: 10.1080/07853890.2022.2163053.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsColchicine at a Low Dose Reduces Liver Inflammation in a Model of Immune-Mediated Hepatitis
Azmanov H, Keidar-Haran T, Kenig A, Kessler A, Kolben Y, Weksler- Zangen S, Ilan Y. Colchicine at a Low Dose Reduces Liver Inflammation in a Model of Immune-Mediated Hepatitis. Archives Of Clinical And Biomedical Research 2023, 07 DOI: 10.26502/acbr.50170334.Peer-Reviewed Original Research
2022
Hemorrhagic Fever with Renal Syndrome Caused by Hantavirus Infection: First Reported Case in Israel.
Kolben Y, Azmanov H, Ishay Y, Orenbuch-Harroch E, Milgrom Y. Hemorrhagic Fever with Renal Syndrome Caused by Hantavirus Infection: First Reported Case in Israel. Israel Medical Association Journal 2022, 24: 621-622. PMID: 36168171.Peer-Reviewed Original ResearchDigital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects
Azmanov H, Bayatra A, Ilan Y. Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects. Journal Of Pain Research 2022, 15: 1051-1060. PMID: 35444460, PMCID: PMC9013915, DOI: 10.2147/jpr.s356319.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements